Connection

Raymond DuBois to Animals

Back to Details
This is a "connection" page, showing publications Raymond DuBois has written about Animals.
Raymond DuBois
Connection Strength
1.736
Animals
  1. The COX-2-PGE2 Pathway Promotes Tumor Evasion in Colorectal Adenomas. Cancer Prev Res (Phila). 2022 05 03; 15(5):285-296.
    View in: PubMed
    Score: 0.060
  2. Cyclooxygenases and Prostaglandins in Tumor Immunology and Microenvironment of Gastrointestinal Cancer. Gastroenterology. 2021 12; 161(6):1813-1829.
    View in: PubMed
    Score: 0.058
  3. Mutant APC promotes tumor immune evasion via PD-L1 in colorectal cancer. Oncogene. 2021 10; 40(41):5984-5992.
    View in: PubMed
    Score: 0.057
  4. PPARd Mediates the Effect of Dietary Fat in Promoting Colorectal Cancer Metastasis. Cancer Res. 2019 09 01; 79(17):4480-4490.
    View in: PubMed
    Score: 0.050
  5. Role of prostanoids in gastrointestinal cancer. J Clin Invest. 2018 07 02; 128(7):2732-2742.
    View in: PubMed
    Score: 0.046
  6. CXCL1 Is Critical for Premetastatic Niche Formation and Metastasis in Colorectal Cancer. Cancer Res. 2017 07 01; 77(13):3655-3665.
    View in: PubMed
    Score: 0.043
  7. The Role of Prostaglandin E(2) in Tumor-Associated Immunosuppression. Trends Mol Med. 2016 Jan; 22(1):1-3.
    View in: PubMed
    Score: 0.039
  8. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice. Gastroenterology. 2015 Dec; 149(7):1884-1895.e4.
    View in: PubMed
    Score: 0.038
  9. CG100649, a novel COX-2 inhibitor, inhibits colorectal adenoma and carcinoma growth in mouse models. Invest New Drugs. 2014 Dec; 32(6):1105-1112.
    View in: PubMed
    Score: 0.035
  10. Peroxisome proliferator-activated receptor d promotes colonic inflammation and tumor growth. Proc Natl Acad Sci U S A. 2014 May 13; 111(19):7084-9.
    View in: PubMed
    Score: 0.035
  11. Role of inflammation and inflammatory mediators in colorectal cancer. Trans Am Clin Climatol Assoc. 2014; 125:358-72; discussion 372-3.
    View in: PubMed
    Score: 0.034
  12. CXCR2-expressing myeloid-derived suppressor cells are essential to promote colitis-associated tumorigenesis. Cancer Cell. 2013 Nov 11; 24(5):631-44.
    View in: PubMed
    Score: 0.034
  13. An inflammatory mediator, prostaglandin E2, in colorectal cancer. Cancer J. 2013 Nov-Dec; 19(6):502-10.
    View in: PubMed
    Score: 0.033
  14. HIG2 promotes colorectal cancer progression via hypoxia-dependent and independent pathways. Cancer Lett. 2013 Dec 01; 341(2):159-65.
    View in: PubMed
    Score: 0.033
  15. Metronomic topotecan for colorectal cancer: a promising new option. Gut. 2013 Feb; 62(2):190-1.
    View in: PubMed
    Score: 0.030
  16. Overview of the AACR Clinical and Translational Cancer Research Think Tank meeting. Clin Cancer Res. 2012 Feb 01; 18(3):607-11.
    View in: PubMed
    Score: 0.030
  17. Prostaglandin E2 promotes intestinal tumor growth via DNA methylation. Nat Med. 2012 Jan 22; 18(2):224-6.
    View in: PubMed
    Score: 0.030
  18. Epoxyeicosatrienoic acids: a double-edged sword in cardiovascular diseases and cancer. J Clin Invest. 2012 Jan; 122(1):19-22.
    View in: PubMed
    Score: 0.029
  19. ANGPTL4 induction by prostaglandin E2 under hypoxic conditions promotes colorectal cancer progression. Cancer Res. 2011 Nov 15; 71(22):7010-20.
    View in: PubMed
    Score: 0.029
  20. Therapeutic potential of peroxisome proliferator-activated receptors in chronic inflammation and colorectal cancer. Gastroenterol Clin North Am. 2010 Sep; 39(3):697-707.
    View in: PubMed
    Score: 0.027
  21. Cyclooxygenase-2 and cancer treatment: understanding the risk should be worth the reward. Clin Cancer Res. 2010 Mar 01; 16(5):1384-90.
    View in: PubMed
    Score: 0.026
  22. Eicosanoids and cancer. Nat Rev Cancer. 2010 Mar; 10(3):181-93.
    View in: PubMed
    Score: 0.026
  23. HEF1 is a crucial mediator of the proliferative effects of prostaglandin E(2) on colon cancer cells. Cancer Res. 2010 Jan 15; 70(2):824-31.
    View in: PubMed
    Score: 0.026
  24. Repression of 15-hydroxyprostaglandin dehydrogenase involves histone deacetylase 2 and snail in colorectal cancer. Cancer Res. 2008 Nov 15; 68(22):9331-7.
    View in: PubMed
    Score: 0.024
  25. Loss of cannabinoid receptor 1 accelerates intestinal tumor growth. Cancer Res. 2008 Aug 01; 68(15):6468-76.
    View in: PubMed
    Score: 0.023
  26. Pro-inflammatory prostaglandins and progression of colorectal cancer. Cancer Lett. 2008 Aug 28; 267(2):197-203.
    View in: PubMed
    Score: 0.023
  27. Regulation of prostaglandin transporters in colorectal neoplasia. Cancer Prev Res (Phila). 2008 Jul; 1(2):93-9.
    View in: PubMed
    Score: 0.023
  28. Targeting cyclooxygenase-2 and the epidermal growth factor receptor for the prevention and treatment of intestinal cancer. Cancer Res. 2007 Oct 01; 67(19):9380-8.
    View in: PubMed
    Score: 0.022
  29. Inflammatory mediators and nuclear receptor signaling in colorectal cancer. Cell Cycle. 2007 Mar 15; 6(6):682-5.
    View in: PubMed
    Score: 0.021
  30. Crosstalk between peroxisome proliferator-activated receptor delta and VEGF stimulates cancer progression. Proc Natl Acad Sci U S A. 2006 Dec 12; 103(50):19069-74.
    View in: PubMed
    Score: 0.021
  31. Gene expression profiling following constitutive activation of MEK1 and transformation of rat intestinal epithelial cells. Mol Cancer. 2006 Nov 17; 5:63.
    View in: PubMed
    Score: 0.021
  32. Emerging roles of beta-arrestins. Cell Cycle. 2006 Sep; 5(18):2060-3.
    View in: PubMed
    Score: 0.020
  33. Repression of prostaglandin dehydrogenase by epidermal growth factor and snail increases prostaglandin E2 and promotes cancer progression. Cancer Res. 2006 Jul 01; 66(13):6649-56.
    View in: PubMed
    Score: 0.020
  34. CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancer. J Exp Med. 2006 Apr 17; 203(4):941-51.
    View in: PubMed
    Score: 0.020
  35. Cyclooxygenase-1-derived PGE2 promotes cell motility via the G-protein-coupled EP4 receptor during vertebrate gastrulation. Genes Dev. 2006 Jan 01; 20(1):77-86.
    View in: PubMed
    Score: 0.019
  36. Connecting COX-2 and Wnt in cancer. Cancer Cell. 2006 Jan; 9(1):6-8.
    View in: PubMed
    Score: 0.019
  37. Ras up-regulation of cyclooxygenase-2. Methods Enzymol. 2006; 407:401-10.
    View in: PubMed
    Score: 0.019
  38. Fishing for prostanoids: deciphering the developmental functions of cyclooxygenase-derived prostaglandins. Dev Biol. 2006 Jan 15; 289(2):263-72.
    View in: PubMed
    Score: 0.019
  39. Prostaglandin E2 regulates the nuclear receptor NR4A2 in colorectal cancer. J Biol Chem. 2006 Feb 03; 281(5):2676-82.
    View in: PubMed
    Score: 0.019
  40. Inflammation in the genesis and perpetuation of cancer: summary and recommendations from a national cancer institute-sponsored meeting. Cancer Res. 2005 Oct 01; 65(19):8583-6.
    View in: PubMed
    Score: 0.019
  41. Mechanisms for the prevention of gastrointestinal cancer: the role of prostaglandin E2. Oncology. 2005; 69 Suppl 1:28-32.
    View in: PubMed
    Score: 0.019
  42. Oncogenic potential of MEK1 in rat intestinal epithelial cells is mediated via cyclooxygenase-2. Gastroenterology. 2005 Aug; 129(2):577-90.
    View in: PubMed
    Score: 0.019
  43. Cyclooxygenase-1 signaling is required for vascular tube formation during development. Dev Biol. 2005 Jun 01; 282(1):274-83.
    View in: PubMed
    Score: 0.019
  44. The role of prostaglandins and other eicosanoids in the gastrointestinal tract. Gastroenterology. 2005 May; 128(5):1445-61.
    View in: PubMed
    Score: 0.019
  45. Prostaglandin E2 enhances intestinal adenoma growth via activation of the Ras-mitogen-activated protein kinase cascade. Cancer Res. 2005 Mar 01; 65(5):1822-9.
    View in: PubMed
    Score: 0.018
  46. WNT and cyclooxygenase-2 cross-talk accelerates adenoma growth. Cell Cycle. 2004 Dec; 3(12):1512-5.
    View in: PubMed
    Score: 0.018
  47. 15-Hydroxyprostaglandin dehydrogenase is down-regulated in colorectal cancer. J Biol Chem. 2005 Feb 04; 280(5):3217-23.
    View in: PubMed
    Score: 0.018
  48. Prostaglandin E2 regulates the complement inhibitor CD55/decay-accelerating factor in colorectal cancer. J Biol Chem. 2005 Jan 07; 280(1):476-83.
    View in: PubMed
    Score: 0.018
  49. Up-regulation of the enzymes involved in prostacyclin synthesis via Ras induces vascular endothelial growth factor. Gastroenterology. 2004 Nov; 127(5):1391-400.
    View in: PubMed
    Score: 0.018
  50. Prostaglandin E(2) promotes colorectal adenoma growth via transactivation of the nuclear peroxisome proliferator-activated receptor delta. Cancer Cell. 2004 Sep; 6(3):285-95.
    View in: PubMed
    Score: 0.018
  51. Cyclooxygenase-2 and gastrointestinal cancer. Cancer J. 2004 May-Jun; 10(3):145-52.
    View in: PubMed
    Score: 0.017
  52. COX-2 inhibition and colorectal cancer. Semin Oncol. 2004 Apr; 31(2 Suppl 7):12-21.
    View in: PubMed
    Score: 0.017
  53. Activation of nuclear hormone receptor peroxisome proliferator-activated receptor-delta accelerates intestinal adenoma growth. Nat Med. 2004 Mar; 10(3):245-7.
    View in: PubMed
    Score: 0.017
  54. Cyclooxygenase-2: a potential target in breast cancer. Semin Oncol. 2004 Feb; 31(1 Suppl 3):64-73.
    View in: PubMed
    Score: 0.017
  55. Cyclooxygenase 2-derived prostaglandin E2 regulates the angiogenic switch. Proc Natl Acad Sci U S A. 2004 Jan 13; 101(2):415-6.
    View in: PubMed
    Score: 0.017
  56. Cyclooxygenase 2 (COX-2) as a target for therapy and noninvasive imaging. Mol Imaging Biol. 2003 Sep-Oct; 5(5):286-303.
    View in: PubMed
    Score: 0.017
  57. Leukotriene A4 signaling, inflammation, and cancer. J Natl Cancer Inst. 2003 Jul 16; 95(14):1028-9.
    View in: PubMed
    Score: 0.016
  58. The cyclooxygenase-2 pathway as a target for treatment or prevention of cancer. Expert Opin Emerg Drugs. 2003 May; 8(1):1-7.
    View in: PubMed
    Score: 0.016
  59. Peroxisome proliferator-activated receptor gamma-mediated differentiation: a mutation in colon cancer cells reveals divergent and cell type-specific mechanisms. J Biol Chem. 2003 Jun 20; 278(25):22669-77.
    View in: PubMed
    Score: 0.016
  60. Cyclooxygenase-2 and colorectal cancer. Prog Exp Tumor Res. 2003; 37:124-37.
    View in: PubMed
    Score: 0.016
  61. New agents for cancer prevention. J Natl Cancer Inst. 2002 Dec 04; 94(23):1732-3.
    View in: PubMed
    Score: 0.016
  62. Peroxisome proliferator-activated receptor gamma and transforming growth factor-beta pathways inhibit intestinal epithelial cell growth by regulating levels of TSC-22. J Biol Chem. 2003 Feb 28; 278(9):7431-8.
    View in: PubMed
    Score: 0.016
  63. Controversy: PPARgamma as a target for treatment of colorectal cancer. Am J Physiol Gastrointest Liver Physiol. 2002 Aug; 283(2):G266-9.
    View in: PubMed
    Score: 0.015
  64. Peroxisome proliferator-activated receptors modulate K-Ras-mediated transformation of intestinal epithelial cells. Cancer Res. 2002 Jun 01; 62(11):3282-8.
    View in: PubMed
    Score: 0.015
  65. COX-2: a target for colon cancer prevention. Annu Rev Pharmacol Toxicol. 2002; 42:55-80.
    View in: PubMed
    Score: 0.015
  66. Changes in cancer cell metabolism revealed by direct sample analysis with MALDI mass spectrometry. PLoS One. 2013; 8(4):e61379.
    View in: PubMed
    Score: 0.008
  67. APOBEC3G promotes liver metastasis in an orthotopic mouse model of colorectal cancer and predicts human hepatic metastasis. J Clin Invest. 2011 Nov; 121(11):4526-36.
    View in: PubMed
    Score: 0.007
  68. In vivo immediate early gene expression induced in intestinal and colonic mucosa by feeding. FEBS Lett. 1991 Aug 05; 287(1-2):102-4.
    View in: PubMed
    Score: 0.007
  69. Prostaglandin Gbetagamma signaling stimulates gastrulation movements by limiting cell adhesion through Snai1a stabilization. Development. 2010 Apr; 137(8):1327-37.
    View in: PubMed
    Score: 0.007
  70. The role of chemokines in intestinal inflammation and cancer. Curr Opin Pharmacol. 2009 Dec; 9(6):688-96.
    View in: PubMed
    Score: 0.006
  71. Stage-specific integration of maternal and embryonic peroxisome proliferator-activated receptor delta signaling is critical to pregnancy success. J Biol Chem. 2007 Dec 28; 282(52):37770-82.
    View in: PubMed
    Score: 0.006
  72. Cyclooxygenase-2-mediated metabolism of arachidonic acid to 15-oxo-eicosatetraenoic acid by rat intestinal epithelial cells. Chem Res Toxicol. 2007 Nov; 20(11):1665-75.
    View in: PubMed
    Score: 0.005
  73. Inhibition of epidermal growth factor receptor signaling elevates 15-hydroxyprostaglandin dehydrogenase in non-small-cell lung cancer. Cancer Res. 2007 Jun 15; 67(12):5587-93.
    View in: PubMed
    Score: 0.005
  74. Extracellular signal-regulated kinase is a target of cyclooxygenase-1-peroxisome proliferator-activated receptor-delta signaling in epithelial ovarian cancer. Cancer Res. 2007 Jun 01; 67(11):5285-92.
    View in: PubMed
    Score: 0.005
  75. MEK activation suppresses CPT11-induced apoptosis in rat intestinal epithelial cells through a COX-2-dependent mechanism. Dig Dis Sci. 2007 Oct; 52(10):2757-65.
    View in: PubMed
    Score: 0.005
  76. Bmp signaling is required for intestinal growth and morphogenesis. Dev Dyn. 2006 Jun; 235(6):1563-70.
    View in: PubMed
    Score: 0.005
  77. Cyclopentenone isoprostanes inhibit the inflammatory response in macrophages. J Biol Chem. 2005 Oct 21; 280(42):35562-70.
    View in: PubMed
    Score: 0.005
  78. Cyclooxygenase-2-mediated DNA damage. J Biol Chem. 2005 Aug 05; 280(31):28337-46.
    View in: PubMed
    Score: 0.005
  79. Cyclooxygenase-1 is a potential target for prevention and treatment of ovarian epithelial cancer. Cancer Res. 2005 May 01; 65(9):3735-44.
    View in: PubMed
    Score: 0.005
  80. Requirement of phospholipase D1 activity in H-RasV12-induced transformation. Proc Natl Acad Sci U S A. 2005 Feb 01; 102(5):1638-42.
    View in: PubMed
    Score: 0.005
  81. Aberrant cannabinoid signaling impairs oviductal transport of embryos. Nat Med. 2004 Oct; 10(10):1074-80.
    View in: PubMed
    Score: 0.004
  82. Effects of transforming growth factor-alpha (TGF-alpha) in vitro and in vivo on reovirus replication. DNA Cell Biol. 2004 Jul; 23(7):430-41.
    View in: PubMed
    Score: 0.004
  83. Intestinal transformation results in transforming growth factor-beta-dependent alteration in tumor cell-cell matrix interactions. Surgery. 2003 May; 133(5):568-79.
    View in: PubMed
    Score: 0.004
  84. Targeted lipidomics using electron capture atmospheric pressure chemical ionization mass spectrometry. Rapid Commun Mass Spectrom. 2003; 17(19):2168-76.
    View in: PubMed
    Score: 0.004
  85. Expression of hypoxia-inducible factors in the peri-implantation mouse uterus is regulated in a cell-specific and ovarian steroid hormone-dependent manner. Evidence for differential function of HIFs during early pregnancy. J Biol Chem. 2003 Feb 28; 278(9):7683-91.
    View in: PubMed
    Score: 0.004
  86. New avenues for the prevention of colorectal cancer: targeting cyclo-oxygenase-2 activity. Best Pract Res Clin Gastroenterol. 2002 Dec; 16(6):945-56.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.